<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0081">
 <label>81</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Jagtap</surname>
    <given-names>AD</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chang</surname>
    <given-names>PT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>JR</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2014</year>;
  <volume>85</volume>:
  <fpage>268</fpage>–
  <lpage>88</lpage>.
  <pub-id pub-id-type="pmid">25089810</pub-id>
 </mixed-citation>
</ref>
